Startseite>>Natural Products>>Laurolitsine hydrochloride

Laurolitsine hydrochloride (Synonyms: (+)-Norboldine hydrochloride)

Katalog-Nr.GC60977

Laurolitsinhydrochlorid ist ein aus Phoebe formosana isoliertes Alkaloid und zeigt eine schwache entzÜndungshemmende AktivitÄt.

Products are for research use only. Not for human use. We do not sell to patients.

Laurolitsine hydrochloride Chemische Struktur

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
371,00 $
Auf Lager
1mg
139,00 $
Auf Lager
5mg
482,00 $
Auf Lager
10mg
853,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Laurolitsine hydrochloride is an alkaloid isolated from Phoebe formosana, and shows weak anti-inflammatory activity.

Laurolitsine shows weak anti-inflammatory activity against NO production in RAW 267.4 and BV-2 cells[1]. Boldine, laurolitsine and litebamine (300 μM) remarkedly inhibit the aggregation of rabbit platelets induced by arachidonic acid (100 μM) and collagen (10 μM/mL), and slightly inhibit that induced by ADP (20 μM)[2].

[1]. Zhang SY, et al. [Alkaloids from roots and stems of Litsea cubeba]. Zhongguo Zhong Yao Za Zhi. 2014 Oct;39(20):3964-8. [2]. Teng CM, et al. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. J Pharm Pharmacol. 1997 Jul;49(7):706-11.

Bewertungen

Review for Laurolitsine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Laurolitsine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.